A Phase 2 Trial of the Multi-targeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC)

Autor:	Schlumberger, Martin, Jarzab, Barbara, Cabanillas, Maria E, Robinson, Bruce G, Pacini, Furio, Ball, Douglas W, Mccaffrey, Judith C, Newbold, Katie L, Allison, Roger, Martins, Renato G, Licitra, Lisa, Shah, Manisha H, Bodenner, Donald, Elisei, Rossella, Burmeister, Lynn, Funahashi, Yasuhiro, Ren, Min, O'Brien, James P, Sherman, Steven I.
Rok vydání:	2015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3728::3870b3154fcc48d3bd1135afc85c4964 http://hdl.handle.net/11568/756261 Zobrazit plný text záznamu